171 related articles for article (PubMed ID: 2599996)
1. Penetration of macrolides into human polymorphonuclear leucocytes.
Ishiguro M; Koga H; Kohno S; Hayashi T; Yamaguchi K; Hirota M
J Antimicrob Chemother; 1989 Nov; 24(5):719-29. PubMed ID: 2599996
[TBL] [Abstract][Full Text] [Related]
2. Influence of azithromycin and other macrolides on the intracellular killing of Staphylococcus aureus by human polymorphonuclear leucocytes of healthy donors and a patient with Chédiak-Higashi syndrome.
Paulsen P; Simon C; Peters O; Hedderich J; Heim P
Chemotherapy; 1992; 38(3):185-90. PubMed ID: 1324831
[TBL] [Abstract][Full Text] [Related]
3. A new macrolide, TE-031 (A-56268), in treatment of experimental Legionnaires' disease.
Kohno S; Koga H; Yamaguchi K; Masaki M; Inoue Y; Dotsu Y; Masuyama Y; Hayashi T; Hirota M; Saito A
J Antimicrob Chemother; 1989 Sep; 24(3):397-405. PubMed ID: 2530201
[TBL] [Abstract][Full Text] [Related]
4. In vitro and ex vivo effects of recent and new macrolide antibiotics on chemotaxis of human polymorphonuclear leukocytes.
Torre D; Broggini M; Bottà V; Sampietro C; Busarello R; Garberi C
J Chemother; 1991 Aug; 3(4):236-9. PubMed ID: 1779257
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of macrolides on human phagocytic functions.
Fietta A; Bersani C; Santagada T; Bertoletti R; Gialdroni Grassi G
Chemioterapia; 1987 Feb; 6(1):52-6. PubMed ID: 3829136
[TBL] [Abstract][Full Text] [Related]
6. Uptake of flurithromycin by human polymorphonuclear phagocytes: partial characterization of the entry mechanism.
Fietta A; Boeri P; Colombo ML; Merlini C; Gialdroni Grassi G
Chemotherapy; 1992; 38(6):433-40. PubMed ID: 1288969
[TBL] [Abstract][Full Text] [Related]
7. Cellular accumulation of the new ketolide RU 64004 by human neutrophils: comparison with that of azithromycin and roxithromycin.
Vazifeh D; Abdelghaffar H; Labro MT
Antimicrob Agents Chemother; 1997 Oct; 41(10):2099-107. PubMed ID: 9333032
[TBL] [Abstract][Full Text] [Related]
8. Effect of azithromycin, roxithromycin and erythromycin on human polymorphonuclear leukocyte function against Staphylococcus aureus.
Pascual A; López-López G; Aragón J; Perea EJ
Chemotherapy; 1990; 36(6):422-7. PubMed ID: 1963394
[TBL] [Abstract][Full Text] [Related]
9. Effect of telithromycin (HMR 3647) on polymorphonuclear neutrophil killing of Staphylococcus aureus in comparison with roxithromycin.
Vazifeh D; Abdelghaffar H; Labro MT
Antimicrob Agents Chemother; 2002 May; 46(5):1364-74. PubMed ID: 11959570
[TBL] [Abstract][Full Text] [Related]
10. Influence of macrolide antibiotics on the chemiluminescence of zymosan-activated human neutrophils.
Dumas R; Brouland JP; Tedone R; Descotes J
Chemotherapy; 1990; 36(5):381-4. PubMed ID: 2209171
[TBL] [Abstract][Full Text] [Related]
11. The in vitro activity of some 14-, 15- and 16- membered macrolides against Staphylococcus spp., Legionella spp., Mycoplasma spp. and Ureaplasma urealyticum.
Felmingham D; Robbins MJ; Sanghrajka M; Leakey A; Ridgway GL
Drugs Exp Clin Res; 1991; 17(2):91-9. PubMed ID: 1650694
[TBL] [Abstract][Full Text] [Related]
12. Investigation of the in-vitro uptake, intraphagocytic biological activity and effects on neutrophil superoxide generation of dirithromycin compared with erythromycin.
Jooné GK; Van Rensburg CE; Anderson R
J Antimicrob Chemother; 1992 Oct; 30(4):509-23. PubMed ID: 1337069
[TBL] [Abstract][Full Text] [Related]
13. The in vitro effect of macrolides on the interaction of human polymorphonuclear leukocytes with Pseudomonas aeruginosa in biofilm.
Takeoka K; Ichimiya T; Yamasaki T; Nasu M
Chemotherapy; 1998; 44(3):190-7. PubMed ID: 9612609
[TBL] [Abstract][Full Text] [Related]
14. Computer-aided prediction of macrolide antibiotic concentrations in human circulating polymorphonuclear leucocytes.
Bouvier d'Yvoire MJ; Dresco IA; Tulkens PM
J Antimicrob Chemother; 1998 Mar; 41 Suppl B():63-8. PubMed ID: 9579715
[TBL] [Abstract][Full Text] [Related]
15. Accumulation and activity of cethromycin (ABT-773) within human polymorphonuclear leucocytes.
García I; Pascual A; Ballesta S; del Castillo C; Perea EJ
J Antimicrob Chemother; 2003 Jul; 52(1):24-8. PubMed ID: 12805263
[TBL] [Abstract][Full Text] [Related]
16. [Resistance to macrolide antibiotics found in methicillin-resistant Japanese clinical isolates of Staphylococcus aureus in 1996].
Nakamura A; Taniguchi K; Tsurubuchi K; O'Hara K; Sawai T
Jpn J Antibiot; 1998 Jul; 51(7):494-500. PubMed ID: 9755433
[TBL] [Abstract][Full Text] [Related]
17. Macrolides and host defences to respiratory tract pathogens.
Gemmell CG
J Hosp Infect; 1991 Sep; 19 Suppl A():11-9. PubMed ID: 1684978
[TBL] [Abstract][Full Text] [Related]
18. [Intracellular effects of josamycin].
Wildfeuer A; Laufen H; Galle J; Pfänder K
Arzneimittelforschung; 1986; 36(1):127-31. PubMed ID: 3954814
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the in-vitro effect of several macrolides on the oxidative burst of human neutrophils.
Labro MT; el Benna J; Babin-Chevaye C
J Antimicrob Chemother; 1989 Oct; 24(4):561-72. PubMed ID: 2559072
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of the in vitro post-antibiotic effect of C14 macrolides (erythromycin and roxithromycin) and C16 macrolides (josamycin and spiramycin) against Staphylococcus aureus].
Rolin O; Bouanchaud DH
Pathol Biol (Paris); 1989 May; 37(5):375-7. PubMed ID: 2780094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
